X Hu1, T Li, S Bi, Z Jin, G Zhou, C Bai, L Li, Q Cui, W Liu. 1. Cardiovascular Surgery Department, Xijing Hospital, Fourth Military Medical University, XI'an, People's Republic of China.
Abstract
OBJECTIVE: The aim of this study was to observe the preservative effect of hydrogen sulfide (H2S) on donor rat hearts. MATERIALS AND METHODS: The hearts of 24 Sprague-Dawley rats were perfused on a Langendorff perfusion column for 30 minutes. We calculated and recorded the left ventricular-developed pressure (LVDP), and positive and negative derivatives of left ventricular systolic pressure (LVSP; +dP/dt and -dP/dt). Hearts were then arrested and stored for 6 hours at 4 degrees C: group 1, Krebs-Henseleit (KH) solution; group 2, KH solution with 1 micromol/L NaHS; group 3, KH solution with 1 micromol/L NaHS and 10 micromol/L glibenclamide; group 4, St. Thomas II solution. Hearts were transferred back to the Langendorff column. After stabilizing for 30 minutes, LV performance was assessed as before. The donor hearts were kept for pathological study including myocardial water ratio, ATP content, and myocyte apoptosis index. RESULTS: The recovery rates of +dp/dtmax, -dp/dtmax, and LVDP of groups 2 and 4 were much better than those of groups 1 and 3. The hearts contracted immediately after reperfusion in group 4. Ventricular fibrillation was seen before contraction in the other 3 groups, with the longest duration in group. No significant difference in myocardial water ratio was found. The ATP content was the highest in group 2. Apoptosis was observed in the 4 groups with the lowest apoptosis index in group 2. CONCLUSIONS: H2S has a protective effect on rat donor hearts at the concentration of 1 micromol/L. The protective effect is better than that of St. Thomas II solution. The protective effect of H2S can be blocked by glibenclamide.
OBJECTIVE: The aim of this study was to observe the preservative effect of hydrogen sulfide (H2S) on donorrat hearts. MATERIALS AND METHODS: The hearts of 24 Sprague-Dawley rats were perfused on a Langendorff perfusion column for 30 minutes. We calculated and recorded the left ventricular-developed pressure (LVDP), and positive and negative derivatives of left ventricular systolic pressure (LVSP; +dP/dt and -dP/dt). Hearts were then arrested and stored for 6 hours at 4 degrees C: group 1, Krebs-Henseleit (KH) solution; group 2, KH solution with 1 micromol/L NaHS; group 3, KH solution with 1 micromol/L NaHS and 10 micromol/L glibenclamide; group 4, St. Thomas II solution. Hearts were transferred back to the Langendorff column. After stabilizing for 30 minutes, LV performance was assessed as before. The donor hearts were kept for pathological study including myocardial water ratio, ATP content, and myocyte apoptosis index. RESULTS: The recovery rates of +dp/dtmax, -dp/dtmax, and LVDP of groups 2 and 4 were much better than those of groups 1 and 3. The hearts contracted immediately after reperfusion in group 4. Ventricular fibrillation was seen before contraction in the other 3 groups, with the longest duration in group. No significant difference in myocardial water ratio was found. The ATP content was the highest in group 2. Apoptosis was observed in the 4 groups with the lowest apoptosis index in group 2. CONCLUSIONS:H2S has a protective effect on ratdonor hearts at the concentration of 1 micromol/L. The protective effect is better than that of St. Thomas II solution. The protective effect of H2S can be blocked by glibenclamide.
Authors: Timothy J George; George J Arnaoutakis; Claude A Beaty; Simran K Jandu; Lakshmi Santhanam; Dan E Berkowitz; Ashish S Shah Journal: J Surg Res Date: 2012-06-27 Impact factor: 2.192
Authors: Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo Journal: Br J Pharmacol Date: 2014-04 Impact factor: 8.739
Authors: Gábor Szabó; Gábor Veres; Tamás Radovits; Domokos Gero; Katalin Módis; Christiane Miesel-Gröschel; Ferenc Horkay; Matthias Karck; Csaba Szabó Journal: Nitric Oxide Date: 2010-11-19 Impact factor: 4.427
Authors: Jan Breza; Andrea Soltysova; Sona Hudecova; Adela Penesova; Ivan Szadvari; Petr Babula; Barbora Chovancova; Lubomira Lencesova; Ondrej Pos; Jan Breza; Karol Ondrias; Olga Krizanova Journal: BMC Cancer Date: 2018-05-24 Impact factor: 4.430
Authors: Christopher Hine; J Humberto Treviño-Villarreal; Pedro Mejia; Alban Longchamp; Lear E Brace; Eylul Harputlugil; Sarah J Mitchell; Jie Yang; Yihong Guan; Jaroslaw P Maciejewski; Babal K Jha; James R Mitchell Journal: Nutrients Date: 2022-04-06 Impact factor: 5.717
Authors: Imran A Ertugrul; Vincent van Suylen; Kevin Damman; Marie-Sophie L Y de Koning; Harry van Goor; Michiel E Erasmus Journal: Int J Mol Sci Date: 2021-05-27 Impact factor: 5.923